Alnylam Pharmaceuticals
ALNY
#618
Rank
ยฃ23.65 B
Marketcap
ยฃ182.74
Share price
-10.08%
Change (1 day)
52.49%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company